Roth Capital Predicts Aspen Aerogels Q1 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at Roth Capital issued their Q1 2025 earnings per share estimates for Aspen Aerogels in a report released on Thursday, October 17th. Roth Capital analyst C. Moore expects that the construction company will post earnings of $0.02 per share for the quarter. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.05 EPS, Q3 2025 earnings at $0.18 EPS, FY2025 earnings at $0.50 EPS and FY2026 earnings at $1.00 EPS.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same quarter in the previous year, the business earned ($0.22) earnings per share. The firm’s revenue was up 144.4% compared to the same quarter last year.

Other equities research analysts also recently issued reports about the company. Barclays assumed coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target for the company. Benchmark reaffirmed a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Roth Mkm reissued a “buy” rating and issued a $36.00 target price on shares of Aspen Aerogels in a research report on Wednesday, August 21st. HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday. Finally, TD Cowen upped their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels presently has an average rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Price Performance

Shares of ASPN opened at $21.60 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The company has a market capitalization of $1.64 billion, a price-to-earnings ratio of -49.08 and a beta of 2.16. The business’s 50-day moving average is $26.00 and its 200-day moving average is $24.35. Aspen Aerogels has a fifty-two week low of $6.62 and a fifty-two week high of $33.15.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in ASPN. Driehaus Capital Management LLC increased its holdings in shares of Aspen Aerogels by 130.4% in the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after acquiring an additional 1,220,724 shares in the last quarter. American Century Companies Inc. raised its holdings in Aspen Aerogels by 562.3% during the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock worth $18,382,000 after buying an additional 654,350 shares during the period. Millennium Management LLC acquired a new position in shares of Aspen Aerogels in the second quarter valued at approximately $9,339,000. Hood River Capital Management LLC increased its position in shares of Aspen Aerogels by 12.2% during the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after acquiring an additional 357,895 shares in the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in shares of Aspen Aerogels during the second quarter worth $8,340,000. Institutional investors own 97.64% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.